The pharmaceutical industry continues to be a hotbed of innovation, with activity driven by the evolution of new treatment paradigms, and the gravity of unmet needs, as well as the growing importance of technologies such as pharmacogenomics, digital therapeutics, and artificial intelligence. In the last three years alone, there have been over 633,000 patents filed and granted in the pharmaceutical industry, according to GlobalData’s report on Chemotherapy in Pharmaceuticals: Platinum-based cancer drug compositions. Buy the report here.

Smarter leaders trust GlobalData

According to GlobalData’s Technology Foresights, which uses over 756,000 patents to analyse innovation intensity for the pharmaceutical industry, there are 110 innovation areas that will shape the future of the industry.

Platinum-based cancer drug compositions is a key innovation area in chemotherapy

Platinum-based drugs are chemotherapeutic agents used for the treatment of cancer. Several platinum-based drugs such as cisplatin, carboplatin and oxaliplatin are widely used in cancer therapy. These compounds cause their therapeutic effect by inhibiting DNA synthesis.

GlobalData’s analysis also uncovers the companies at the forefront of each innovation area and assesses the potential reach and impact of their patenting activity across different applications and geographies.  According to GlobalData, there are 320+ companies, spanning technology vendors, established pharmaceutical companies, and up-and-coming start-ups engaged in the development and application of platinum-based cancer drug compositions.

Key players in platinum-based cancer drug compositions – a disruptive innovation in the pharmaceutical industry

‘Application diversity’ measures the number of different applications identified for each relevant patent and broadly splits companies into either ‘niche’ or ‘diversified’ innovators.

‘Geographic reach’ refers to the number of different countries each relevant patent is registered in and reflects the breadth of geographic application intended, ranging from ‘global’ to ‘local’.

Patent volumes related to platinum-based cancer drug compositions

Company Total patents (2010 - 2022) Premium intelligence on the world's largest companies
Bristol-Myers Squibb 281 Unlock Company Profile
F. Hoffmann-La Roche 258 Unlock Company Profile
Otsuka Holdings 250 Unlock Company Profile
Vertex Pharmaceuticals 247 Unlock Company Profile
E. Merck 184 Unlock Company Profile
Eli Lilly and 167 Unlock Company Profile
Amgen 130 Unlock Company Profile
Pharma Mar 120 Unlock Company Profile
Pierre Fabre Foundation 115 Unlock Company Profile
Bayer 113 Unlock Company Profile
Pfizer 101 Unlock Company Profile
Ipsen 86 Unlock Company Profile
AbbVie 80 Unlock Company Profile
Regeneron Pharmaceuticals 79 Unlock Company Profile
C. H. Boehringer Sohn 79 Unlock Company Profile
Johnson & Johnson 78 Unlock Company Profile
Eagle Pharmaceuticals 71 Unlock Company Profile
Esteve Pharmaceuticals 70 Unlock Company Profile
Merrimack Pharmaceuticals 68 Unlock Company Profile
Arcus Biosciences 61 Unlock Company Profile
Takeda Pharmaceutical 61 Unlock Company Profile
Mayo Clinic 60 Unlock Company Profile
Komipharm International 60 Unlock Company Profile
Novartis 59 Unlock Company Profile
Spectrum Pharmaceuticals 58 Unlock Company Profile
TesoRx Pharma 55 Unlock Company Profile
GSK 53 Unlock Company Profile
CanBas 52 Unlock Company Profile
NanoCarrier 47 Unlock Company Profile
City of Hope 46 Unlock Company Profile
Sprint Bioscience 45 Unlock Company Profile
Merck & Co 45 Unlock Company Profile
Promontory Therapeutics 45 Unlock Company Profile
Sanofi 45 Unlock Company Profile
Mallinckrodt 45 Unlock Company Profile
Eisai 44 Unlock Company Profile
NuCana 44 Unlock Company Profile
Bio-Bedst 44 Unlock Company Profile
Centre National de la Recherche Scientifique 43 Unlock Company Profile
Astellas Pharma 43 Unlock Company Profile
LEAF Holdings Group 42 Unlock Company Profile
Aslan Pharmaceuticals 42 Unlock Company Profile
Superlab Far East 41 Unlock Company Profile
United Nations Industrial Development Organization 41 Unlock Company Profile
MEI Pharma 40 Unlock Company Profile
Ono Pharmaceutical 39 Unlock Company Profile
Polaris Pharmaceutical Group 39 Unlock Company Profile
Myriad Genetics 38 Unlock Company Profile
Intezyne 37 Unlock Company Profile
Nippon Kayaku 36 Unlock Company Profile

Source: GlobalData Patent Analytics

Bristol-Myers Squibb is one of the leading patent filers in platinum-based drugs. The company has filed several patents involving platinum compounds and developed drugs such as cisplatin and carboplatin..

In terms of application diversity, Synlogic is the top company, followed by Traslational Cancer Drugs Pharma and
Calgent Biotechnology. By means of geographic reach, Nanobiotix holds the top position. BioMarin Pharmaceutical and Eisai are in second and third positions, respectively.

To further understand the key themes and technologies disrupting the pharmaceutical industry, access GlobalData’s latest thematic research report on Immuno-Oncology – Thematic Research.

Premium Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData’s Patent Analytics tracks patent filings and grants from official offices around the world. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.